메뉴 건너뛰기




Volumn 142, Issue 5, 2012, Pages 1175-1178

Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for VTE prophylaxis?

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

EID: 84868611638     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2926     Document Type: Article
Times cited : (10)

References (23)
  • 2
    • 70449724750 scopus 로고    scopus 로고
    • Inpatient thromboprophylaxis use in U.S. hospitals: Adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients
    • Amin AN, Stemkowski S, Lin J, Yang G. Inpatient thromboprophylaxis use in U.S. hospitals: adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients. J Hosp Med. 2009;4(8):E15-21.
    • (2009) J Hosp Med , vol.4 , Issue.8
    • Amin, A.N.1    Stemkowski, S.2    Lin, J.3    Yang, G.4
  • 3
    • 77949912886 scopus 로고    scopus 로고
    • Designing and implementing effective venous thromboembolism prevention protocols: Lessons from collaborative efforts
    • Maynard G, Stein J. Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis. 2010;29(2):159-166.
    • (2010) J Thromb Thrombolysis , vol.29 , Issue.2 , pp. 159-166
    • Maynard, G.1    Stein, J.2
  • 4
    • 0029852157 scopus 로고    scopus 로고
    • Heparin-induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered Procoagulant/Anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia
    • DOI 10.1016/S0887-7963(96)80001-0
    • Warkentin TE. Heparin-induced thrombocytopenia: IgGmediated platelet activation, platelet microparticle generation, and altered procoagulant/ anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Transfus Med Rev. 1996;10(4):249-258. (Pubitemid 26354134)
    • (1996) Transfusion Medicine Reviews , vol.10 , Issue.4 , pp. 249-258
    • Warkentin, T.E.1
  • 5
    • 1242297625 scopus 로고    scopus 로고
    • Treatment of Heparin-Induced Thrombocytopenia: A Critical Review
    • DOI 10.1001/archinte.164.4.361
    • Hirsh J, Heddle N, Kelton JG. Treatment of heparin-induced thrombocytopenia: a critical review. Arch Intern Med. 2004;164(4):361-369. (Pubitemid 38240699)
    • (2004) Archives of Internal Medicine , vol.164 , Issue.4 , pp. 361-369
    • Hirsh, J.1    Heddle, N.2    Kelton, J.G.3
  • 6
    • 33644971524 scopus 로고    scopus 로고
    • Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings
    • Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759-765.
    • (2006) J Thromb Haemost , vol.4 , Issue.4 , pp. 759-765
    • Lo, G.K.1    Juhl, D.2    Warkentin, T.E.3    Sigouin, C.S.4    Eichler, P.5    Greinacher, A.6
  • 7
    • 34247844418 scopus 로고    scopus 로고
    • Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia
    • DOI 10.1309/RPE753J4PMG9773Q
    • Janatpour KA, Gosselin RC, Dager WE, et al. Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparininduced thrombocytopenia. Am J Clin Pathol. 2007;127(3):429-433. (Pubitemid 46806337)
    • (2007) American Journal of Clinical Pathology , vol.127 , Issue.3 , pp. 429-433
    • Janatpour, K.A.1    Gosselin, R.C.2    Dager, W.E.3    Lee, A.4    Owings, J.T.5    Zhou, J.6    Wun, T.7
  • 8
    • 67949124723 scopus 로고    scopus 로고
    • Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia
    • Bakchoul TGA, Giptner A, Najaoui A, Bein G, Santoso S, Sachs UJ. Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost. 2009;7(8):1260-1265.
    • (2009) J Thromb Haemost , vol.7 , Issue.8 , pp. 1260-1265
    • Bakchoul, T.G.A.1    Giptner, A.2    Najaoui, A.3    Bein, G.4    Santoso, S.5    Sachs, U.J.6
  • 9
    • 0030983928 scopus 로고    scopus 로고
    • Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution
    • DOI 10.1002/(SICI)1096-8652(199709)56:1<12::AID-AJH3>3.0.CO;2-5
    • Nand S, Wong W, Yuen B, Yetter A, Schmulbach E, Gross Fisher S. Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Am J Hematol. 1997;56(1):12-16. (Pubitemid 27398052)
    • (1997) American Journal of Hematology , vol.56 , Issue.1 , pp. 12-16
    • Nand, S.1    Wong, W.2    Yuen, B.3    Yetter, A.4    Schmulbach, E.5    Fisher, S.G.6
  • 10
    • 0021262284 scopus 로고
    • Heparin-associated thrombocytopenia
    • King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med. 1984;100(4):535-540. (Pubitemid 14126750)
    • (1984) Annals of Internal Medicine , vol.100 , Issue.4 , pp. 535-540
    • King, D.J.1    Kelton, J.G.2
  • 11
    • 34250856863 scopus 로고    scopus 로고
    • The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital
    • DOI 10.1378/chest.06-2109
    • Smythe MA, Koerber JM, Mattson JC. The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital. Chest. 2007;131(6):1644-1649. (Pubitemid 46981615)
    • (2007) Chest , vol.131 , Issue.6 , pp. 1644-1649
    • Smythe, M.A.1    Koerber, J.M.2    Mattson, J.C.3
  • 12
    • 79952711217 scopus 로고    scopus 로고
    • High rates of venous thromboembolism pro phylaxis did not increase the incidence of heparin-induced thrombocytopenia
    • Jenkins I, Helmons PJ, Martin-Armstrong LM, Montazeri ME, Renvall M. High rates of venous thromboembolism pro phylaxis did not increase the incidence of heparin-induced thrombocytopenia . Jt Comm J Qual Patient Saf. 2011;37(4):163-169.
    • (2011) Jt Comm J Qual Patient Saf , vol.37 , Issue.4 , pp. 163-169
    • Jenkins, I.1    Helmons, P.J.2    Martin-Armstrong, L.M.3    Montazeri, M.E.4    Renvall, M.5
  • 13
    • 67249094457 scopus 로고    scopus 로고
    • Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital
    • Ban-Hoefen M, Francis C. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital. Thromb Res. 2009;124(2):189-192.
    • (2009) Thromb Res , vol.124 , Issue.2 , pp. 189-192
    • Ban-Hoefen, M.1    Francis, C.2
  • 14
    • 0029035681 scopus 로고
    • Heparin-induced thrombocytopenia in patients treated with low-molecularweight heparin or unfractionated heparin
    • Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecularweight heparin or unfractionated heparin. N Engl J Med. 1995;332(20):1330-1335.
    • (1995) N Engl J Med , vol.332 , Issue.20 , pp. 1330-1335
    • Warkentin, T.E.1    Levine, M.N.2    Hirsh, J.3
  • 15
    • 0034284046 scopus 로고    scopus 로고
    • Impact of the patient population on the risk for heparin-induced thrombocytopenia
    • Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood. 2000;96(5):1703-1708. (Pubitemid 30661052)
    • (2000) Blood , vol.96 , Issue.5 , pp. 1703-1708
    • Warkentin, T.E.1    Sheppard, J.-A.I.2    Horsewood, P.3    Simpson, P.J.4    Moore, J.C.5    Kelton, J.G.6
  • 16
    • 27644563148 scopus 로고    scopus 로고
    • The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: A prospective cohort study
    • DOI 10.1182/blood-2005-03-0912
    • Prandoni P, Siragusa S, Girolami B, Fabris F;BELZONI Investigators Group. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecularweight heparin: a prospective cohort study. Blood. 2005;106(9):3049-3054. (Pubitemid 41565898)
    • (2005) Blood , vol.106 , Issue.9 , pp. 3049-3054
    • Prandoni, P.1    Siragusa, S.2    Girolami, B.3    Fabris, F.4
  • 17
    • 4644242157 scopus 로고    scopus 로고
    • Heparin-induced thrombocytopenia: Recognition, treatment, and prevention - The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    • DOI 10.1378/chest.126.3-suppl.311S
    • Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(suppl 3):311S-337S. (Pubitemid 39297959)
    • (2004) Chest , vol.126 , Issue.3 SUPPL.
    • Warkentin, T.E.1    Greinacher, A.2
  • 18
    • 27144527501 scopus 로고    scopus 로고
    • Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis
    • DOI 10.1182/blood-2005-04-1546
    • Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood. 2005;106(8):2710-2715. (Pubitemid 41510744)
    • (2005) Blood , vol.106 , Issue.8 , pp. 2710-2715
    • Martel, N.1    Lee, J.2    Wells, P.S.3
  • 19
    • 34247885965 scopus 로고    scopus 로고
    • Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: Results from a cost-effectiveness analysis
    • DOI 10.1097/MBC.0b013e328099af58, PII 0000172120070600000003
    • Shorr AF, Jackson WL, Weiss BM, Moores LK. Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis. Blood Coagul Fibrinolysis. 2007;18(4):309-316. (Pubitemid 46699406)
    • (2007) Blood Coagulation and Fibrinolysis , vol.18 , Issue.4 , pp. 309-316
    • Shorr, A.F.1    Jackson, W.L.2    Weiss, B.M.3    Moores, L.K.4
  • 20
    • 0034847273 scopus 로고    scopus 로고
    • Enoxaparin for thromboprophylaxis after major trauma: Potential cost implications
    • Shorr AF, Ramage AS. Enoxaparin for thromboprophylaxis after major trauma: potential cost implications. Crit Care Med. 2001;29(9):1659-1665. (Pubitemid 32848361)
    • (2001) Critical Care Medicine , vol.29 , Issue.9 , pp. 1659-1665
    • Shorr, A.F.1    Ramage, A.S.2
  • 21
    • 33750944556 scopus 로고    scopus 로고
    • Outcomes of thromboprophylaxis with enoxaparin vs unfractionated heparin in medical inpatients
    • McGarry LJ, Stokes ME, Thompson D. Outcomes of thromboprophylaxis with enoxaparin vs unfractionated heparin in medical inpatients. Thromb J. 2006;4:17.
    • (2006) Thromb J , vol.4 , pp. 17
    • McGarry, L.J.1    Stokes, M.E.2    Thompson, D.3
  • 22
    • 80053608750 scopus 로고    scopus 로고
    • Low-molecular-weight heparin versus unfractionated heparin for prophylaxis of venous thromboembolism in medicine patients-a pharmacoeconomic analysis
    • Wilbur K, Lynd L, Sadatsafavi M. Low-molecular-weight heparin versus unfractionated heparin for prophylaxis of venous thromboembolism in medicine patients-a pharmacoeconomic analysis. Clin Appl Thromb Hemost. 2011;17(5):454-465.
    • (2011) Clin Appl Thromb Hemost , vol.17 , Issue.5 , pp. 454-465
    • Wilbur, K.1    Lynd, L.2    Sadatsafavi, M.3
  • 23
    • 36749095644 scopus 로고    scopus 로고
    • What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
    • DOI 10.1002/ajh.21032
    • Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Am J Hematol. 2007;82(12):1037-1043. (Pubitemid 350209843)
    • (2007) American Journal of Hematology , vol.82 , Issue.12 , pp. 1037-1043
    • Lo, G.K.1    Sigouin, C.S.2    Warkentin, T.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.